Strategic Roles will build on Market Position

Tim Flanagan has been appointed as Chief Executive Officer at Applied Biophysics a leading company in biomolecules characterisation. At the same time Marc Neglia was announced as company President to lead operations in the Americas and he will also be an executive member of the Board. Tim succeeds Paul Walker who has been acting as Interim CEO for the past year and who will resume his previous role as a non-executive board member after a transition period.

"Tim brings a wealth of relevant experience having been a commercial executive for many organisations which Applied Photophysics respect and admire as peers in the industry. Over the past few months Tim has advised our commercial approach in one of our strategically most important areas. In this period, he has demonstrated his ability to assess, analyse and drive both people and organisations in a commercially successful direction,” said David Berglund, Chairman Applied Photophysics.

Tim has over 25-years of leadership experience in the life sciences tools markets and has previously held senior roles in Bioquell, GE Life Sciences, MicroCal, Bio-Rad, and Beckman Coulter.

Mr Berglund continued: "I would also like to congratulate Marc on his promotion to President of Applied Photophysics Inc. Over his 18 months with us, Marc has demonstrated a strong ability to understand and meet customer needs even in difficult environments. In this short period, Marc has tuned a strong group of individuals into a highly performing team. With the increased control that Applied Photophysics Inc. will give Marc, I am convinced that he will continue to excel in delivering strong results".

With more than 25 years of leadership experience, as North American Sales Director at Applied Photophysics, Marc has helped to re-establish the company as a key player in the protein characterisation market. He holds a BS Degree in Electronics Engineering from Thomas Edison State University and an MBA Degree from Drexel University.